Back
Sage Therapeutics Stock Predictions
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
SAGE
Sage Therapeutics
Last Price:
$8.61
Seasonality Move:
6.64%
7 Day Trial
ALL ACCESS PASS
$
7
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Sage Therapeutics Stock Forecast
-
Over the next 52 weeks, Sage Therapeutics has on average historically risen by 16.3% based on the past 10 years of stock performance.
-
Sage Therapeutics has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Sage Therapeutics Stock Undervalued?The current Sage Therapeutics [SAGE] share price is $8.53. The Score for SAGE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
SAGE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Sage Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Sage Therapeutics has on average historically risen by 16.3% based on the past 10 years of stock performance.
Sage Therapeutics Stock Rating
Sell
47
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics overpriced?
-
Sage Therapeutics has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Sage Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sagerx.com
52-Week Data
52-Week High:
19.34
52-Week Low:
4.62
Prediction Charts
Market Cap:
524.4M
Price in USD:
8.53
Volume:
1.8M
Beta:
1.34
Technical Analysis
SMA50:
7.34
SMA100:
6.56
SMA200:
7.85
52-Wk Change:
-54.36%
Stock Predictions
-
Is Sage Therapeutics stock public?Yes, Sage Therapeutics is a publicly traded company.
-
What is the Sage Therapeutics stock quote today?The Sage Therapeutics stock price is 8.53 USD today.
-
How to buy Sage Therapeutics stock online?You can buy Sage Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-5 | 7.16 | 7.55 | 7.56 | 7.07 |
| Mar-6 | 7.46 | 7.58 | 7.64 | 7.45 |
| Mar-7 | 7.58 | 7.50 | 7.58 | 7.40 |
| Mar-11 | 7.15 | 7.40 | 7.42 | 6.98 |
| Mar-12 | 7.46 | 7.69 | 7.80 | 7.37 |
| Mar-13 | 7.64 | 7.85 | 7.92 | 7.62 |
| Mar-14 | 7.88 | 7.72 | 8.00 | 7.66 |
| Mar-17 | 7.72 | 8.02 | 8.22 | 7.70 |
| Mar-18 | 7.96 | 7.86 | 8.01 | 7.81 |
| Mar-19 | 7.86 | 8.06 | 8.11 | 7.84 |
| Mar-20 | 8.04 | 8.01 | 8.11 | 7.94 |
| Mar-21 | 7.94 | 8.10 | 8.24 | 7.94 |
| Mar-24 | 8.15 | 8.21 | 8.26 | 8.09 |
| Mar-25 | 8.05 | 8.53 | 8.56 | 7.99 |
Sage Therapeutics Earnings
Sage Therapeutics Earnings Report: Per Share Sage Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Sage Therapeutics Forecast Revenue Growth
Sage Therapeutics Stock Analysis: Historical quarterly revenues per share for Sage Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.42 per share, an increase this year of $2.66 per share, and an increase next year of $1.19 per share.
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.